Fred Hassan
Chief Executive Officer, Merck & Co.
Companies
- EyePoint PharmaceuticalsBoard member Sep 5, 2024 to now1
- Cocrystal Pharma, Inc.Board member Apr 27, 2023 to now2
- BridgeBioBoard member Aug 26, 2021 to now3
- Precigen, IncBoard member Jul 7, 2016 to now4
- Prometheus Biosciences, Inc.Board member May 17, 2021 to Jun 16, 20235
- AmgenBoard member Jul 30, 2015 to May 7, 20206
- WarnerMediaBoard member Oct 30, 2009 to Jun 18, 20187
- Bausch HealthBoard member Aug 9, 2013 to Sep 3, 20138
- AVON PRODUCTS INCBoard member May 8, 2006 to May 7, 20129
- Merck & Co.Chief executive officer May 23, 2006 to Nov 4, 200910
- Merck & Co.Chair May 23, 2006 to Nov 4, 200910
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Precigen, Inc PGEN1,243,239 shares11$9.0M at $7.20Mar 13, 2026
BridgeBio BBIO29,879 shares12$2.0M at $66.39Jun 22, 2026- Cocrystal Pharma, Inc. COCP1,383,009 shares13$1.4M at $1.02Oct 28, 2025
- Prometheus Biosciences, Inc.0 shares14Jun 16, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 22, 2026Granted 3,990 shares of BridgeBio12
- Mar 13, 2026Exercised options 71,839 shares of Precigen, Inc11
- Mar 10, 2026Granted 17,948 shares at $3.51 of Precigen, Inc15
- Oct 28, 2025Granted 359,713 shares at $1.39 of Cocrystal Pharma, Inc.13
- Jun 20, 2025Granted 6,589 shares of BridgeBio16
- Mar 14, 2025Exercised options 87,412 shares of Precigen, Inc17
- Mar 13, 2025Granted 36,206 shares at $1.74 of Precigen, Inc17
- Oct 9, 2024Granted 8,067 shares of Cocrystal Pharma, Inc.18
- Mar 14, 2024Granted 44,055 shares at $1.43 of Precigen, Inc19
- Mar 9, 2024Exercised options 106,837 shares of Precigen, Inc20
- Aug 14, 2023Bought 570,345 shares at $1.75 of Precigen, Inc21
- Jun 16, 2023Returned to company 2,123 shares of Prometheus Biosciences, Inc.14
- May 19, 2023Granted 2,123 shares of Prometheus Biosciences, Inc.22
- Mar 9, 2023Granted 48,290 shares at $1.17 of Precigen, Inc23
- Feb 22, 2023Exercised options 61,576 shares of Precigen, Inc24
- Mar 25, 2022Exercised options 16,212 shares of Precigen, Inc25
- Feb 22, 2022Granted 27,832 shares at $2.03 of Precigen, Inc26
- Dec 29, 2021Bought 19,300 shares at $14.17 of BridgeBio27
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARCocrystal Pharma, Inc., Board member
- 3SEC EDGARBridgeBio, Board member
- 4SEC EDGARPrecigen, Inc, Board member
- 5
- 6SEC EDGARAmgen, Board member
- 7SEC EDGARWarnerMedia, Board member
- 8SEC EDGARBausch Health, Board member
- 9SEC EDGARAVON PRODUCTS INC, Board member
- 10SEC EDGARMerck & Co., Chief executive officer
- 11
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Mar 12, 2026
- 16SEC EDGARForm 4 filed Jun 24, 2025
- 17SEC EDGARForm 4 filed Mar 17, 2025
- 18SEC EDGARForm 4 filed Oct 11, 2024
- 19SEC EDGARForm 4 filed Mar 18, 2024
- 20SEC EDGARForm 4 filed Mar 12, 2024
- 21SEC EDGARForm 4 filed Aug 16, 2023
- 22SEC EDGARForm 4 filed May 19, 2023
- 23SEC EDGARForm 4 filed Mar 13, 2023
- 24SEC EDGARForm 4 filed Feb 24, 2023
- 25SEC EDGARForm 4 filed Mar 29, 2022
- 26SEC EDGARForm 4 filed Feb 24, 2022
- 27SEC EDGARForm 4 filed Jan 3, 2022